Avidity Biosciences Inc
(RNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,394 | -173,995 | -123,524 | -79,925 | -34,235 |
| Depreciation Amortization | -1,840 | 772 | 1,190 | 859 | 478 |
| Other Working Capital | -4,525 | 7,067 | 3,355 | -179 | -2,055 |
| Other Operating Activity | 9,792 | 29,888 | 21,900 | 14,125 | 6,238 |
| Operating Cash Flow | $-48,967 | $-136,268 | $-97,079 | $-65,120 | $-29,574 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -193,860 | -187,132 | -180,214 | -191,039 | -174,717 |
| PPE Investments | -1,820 | -2,823 | -1,973 | -2,080 | -758 |
| Investing Cash Flow | $-195,680 | $-189,955 | $-182,187 | $-193,119 | $-175,475 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 22,961 | 346,171 | 102,517 | 62,897 | 24,113 |
| Financing Cash Flow | $22,961 | $346,171 | $102,517 | $62,897 | $24,113 |
| Beginning Cash Position | 340,647 | 320,699 | 320,699 | 320,699 | 320,699 |
| End Cash Position | 118,961 | 340,647 | 143,950 | 125,357 | 139,763 |
| Net Cash Flow | $-221,686 | $19,948 | $-176,749 | $-195,342 | $-180,936 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,967 | -136,268 | -97,079 | -65,120 | -29,574 |
| Capital Expenditure | -1,820 | -2,823 | -1,973 | -2,080 | -758 |
| Free Cash Flow | -50,787 | -139,091 | -99,052 | -67,200 | -30,332 |